Re: Effect of alcoholic extract of nigella sativa on cisplatininduced toxicity in rat

Iranian Journal of Kidney Diseases

Volumn 7, Issue 2, 2013, Pages 165-166

  Nematbakhsh, Mehdi ^a   Nasri, Hamid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; ERYTHROPOIETIN; ESTROGEN; LOSARTAN; MAGNESIUM; NIGELLA SATIVA EXTRACT;

CISPLATIN INDUCED NEPHROTOXICITY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; ESTROGEN ACTIVITY; EXPERIMENTAL MODEL; KIDNEY DYSFUNCTION; LETTER; LOW DRUG DOSE; NEPHROTOXICITY; NONHUMAN; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; KIDNEY DISEASES; MALE; NIGELLA SATIVA; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84875180070     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Hadjzadeh MA, Keshavarzi Z, Tabatabaee Yazdi SA, Ghasem Shirazi M, Rajaei Z, Khajavi Rad A. Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat. Iran J Kidney Dis. 2012;6:99-104.
2. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci. 2011;16:1389-1396.
3. Nematbakhsh M, Ashrafi F, Safari T, et al. Administration of vitamin E and losartan as prophylaxes in cisplatininduced nephrotoxicity model in rats. J Nephrol. 2012; 25:410-417.
4. Ashrafi F, Haghshenas S, Nematbakhsh M, et al. The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect. Int J Prev Med. 2012;3:637-643.
5. Ashrafi F, Nematbakhsh M, Safari T, et al. A combination of vitamin c and losartan for cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis. 2012;6:361-365.
6. Nematbakhsh M, Ashrafi F, Pezeshki Z, et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model. J Nephropathol. 2012;1:190-193.
7. Haghighi M, Nematbakhsh M, Talebi A, et al. The role of angiotensin II receptor 1 (AT1) blockade in cisplatininduced nephrotoxicity in rats: gender-related differences. Ren Fail. 2012;34:1046-1051.
8. Nematbakhsh M, Pezeshki Z, Eshraghi-Jazi F, et al. Vitamin E, vitamin C, or losartan is not nephroprotectant against cisplatin-induced nephrotoxicity in presence of estrogen in ovariectomized rat model. Int J Nephrol. 2012;2012:284896.
9. Pezeshki Z, Nematbakhsh M, Mazaheri S, et al. Estrogen abolishes protective effect of erythropoietin against cisplatin-induced nephrotoxicity in ovariectomized rats. ISRN Oncology. 2012;2012:890310.
10. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, et al. Erythropoietin ameliorates gentamycin-induced renal toxicity: A biochemical and histopathological study. J Nephropathol. 2012;1:109-116.
11. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathol. 2012;1:81-82.
12. Tavafi M. Inhibition of gentamicin induced renal tubular cell necrosis. J Nephropathol. 2012;1:83-86.
13. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathol. 2012;1:123-125.
14. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012;1:162-163.
15. Assadi F. The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol. 2012;1:61-64.
16. Nematbakhsh M, Talebi A, Nasri H, et al. Some evidence for sex-based differences in cisplatininduced nephrotoxicity in rats. Clin Exp Med Letter. 2012;53:29-32.